Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways

Abstract

Metastasis suppressors and associated other regulators of cell motility play a critical initial role in tumor invasion and metastases. Benzyl isothiocyanate (BITC) is a hydrolysis compound of glucotropaeolin in dietary cruciferous vegetables. BITC has been found to exhibit prevention of cancers in laboratory animals and might also be chemoprotective in humans. Here, the purpose of this study was to investigate the effects of BITC on cell proliferation, migration, invasion and mitogen-activated protein kinase (MAPK) pathways of AGS human gastric cancer cells. Wound healing and Boyden chamber (migration and invasion) assays demonstrated that BITC exhibited an inhibitory effect on the abilities of migration and invasion in AGS cancer cells. BITC suppressed cell migration and invasion of AGS cells in a dose-dependent manner. Results from Western blotting indicated that BITC exerted an inhibitory effect on the ERK1/2, Ras, GRB2, Rho A, iNOS, COX-2 for causing the inhibitions of MMP-2, -7 and -9 then followed by the inhibitions of invasion and migration of AGS cells in vitro. BITC also promoted MKK7, MEKK3, c-jun, JNK1/2, VEGF, Sos1, phosphoinositide 3-kinase (PI3K), PKC, nuclear factor-kappaB (NF-κB) p65 in AGS cells. Results from real-time polymerized chain reaction (PCR) showed that BITC inhibited the gene expressions of MMP-2,-7 -9, FAK, ROCK1 and RhoA after BITC treatment for 24 and 48 hours in AGS cells. Taken together, the finding may provide new mechanisms and functions of BITC, which inhibit migration and invasion of human gastric cancer AGS cells.

Keywords

BITC migration invasion MMP-2 MMP-9 human gastric cancer AGS cells

References

Ajani JA Evolving chemotherapy for advanced gastric cancer. Oncologist 2005; 3: 49-58.

Conaway CC , Yang YM , Chung FL Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002; 3: 233-255.

Kilian M. , Gregor JI , Heukamp I. , et al. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 429-434.

Mizutani K. , Kofuji K. , Shirouzu K. The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg Today 2000; 30: 614-621.

Gullu IH , Kurdoglu M. , Akalin I. The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer. Br J Cancer 2000; 82: 249.

Donadio AC , Remedi MM , Susperreguy S. , et al. Extracellular matrix metalloproteinase inducer (EMM-PRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats. Histochem Cell Biol 2008; 130: 1155-1164.

Cortes-Reynosa P. , Robledo T. , Macias-Silva M. , et al. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 2008; 27: 220-231.

Bernhard EJ , Gruber SB , Muschel RJ Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A 1994; 91: 4293-4297.

Guruvayoorappan C. , Kuttan G. Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 2008; 30: 711-727.

10.

Okada N. , Ishida H. , Murata N. , et al. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. Biochem Biophys Res Commun 2001; 288: 212-216.

11.

Waas ET , Wobbes T. , Lomme RM , et al. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 2003; 90: 1556-1564.

12.

Hecht SS Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 2000; 32: 395-411.

13.

Talalay P. , Fahey JW Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 2001; 131: 3027S-3033S.

14.

Miyoshi N. , Uchida K. , Osawa T. , et al. A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 2004; 64: 2134-2142.

15.

Lin JM , Amin S. , Trushin N. , et al. Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Lett 1993; 74: 151-159.

16.

Sugie S. , Okumura A. , Tanaka T. , et al. Inhibitory effects of benzyl isothiocyanate and benzyl thiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn J Cancer Res 1993; 84: 865-870.

17.

Wattenberg LW Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J Natl Cancer Inst 1977; 58: 395-398.

18.

Lui VW , Wentzel AL , Xiao D. , et al. Requirement of a carbon spacer in benzyl isothiocyanate-mediated cytotoxicity and MAPK activation in head and neck squamous cell carcinoma . Carcinogenesis 2003; 24: 1705-1712.

19.

Yang YM , Conaway CC , Chiao JW , et al. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res 2002; 62: 2-7.

20.

Zhang Y. , Tang L. , Gonzalez V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells . Mol Cancer Ther 2003; 2: 1045-1052.

21.

Jakubikova J. , Sedlak J. , Bacon J. , et al. Effects of MEK1 and PI3K inhibitors on allyl-, benzyl- and phenylethyl-isothiocyanate-induced G2/M arrest and cell death in Caco-2 cells. Int J Oncol 2005 ; 27: 1449-1458.

22.

Srivastava SK , Singh SV Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 2004; 25: 1701-1709.

23.

Xiao D. , Vogel V. , Singh SV Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther 2006; 5: 2931-2945.

24.

Ho YT , Yang JS , Li TC , et al. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 2009; 279: 155-162.

25.

Lu HF , Wang HL , Chuang YY , et al. Danthron induced apoptosis through mitochondria and caspase-3-dependent pathways in human brain glioblastoma multiforms GBM 8401 Cells. Neurochem Res 2010; 35: 390-398.

26.

Lin SS , Lai KC , Hsu SC , et al Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett 2009; 285: 127-133.

27.

Lin CC , Chen JT , Yang JS , et al. Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9. Oncol Rep 2009; 22: 1033-1037.

28.

Lu HF , Lai KC , Hsu SC , et al. Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells . Oncol Rep 2009; 22: 97-104.

29.

Liotta LA , Stetler-Stevenson WG Tumor invasion and metastasis: an imbalance of positive and negative regulation . Cancer Res 1991; 51: 5054s-5059s.

30.

Monig SP , Baldus SE , Hennecken JK , et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2001; 39: 597-602.

31.

Murray GI , Duncan ME , Arbuckle E. , et al. Matrix metalloproteinases and their inhibitors in gastric cancer . Gut 1998; 43: 791-797.

32.

Honda M. , Mori M. , Ueo H. , et al. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 1996; 39: 444-448.

33.

Yamashita K. , Azumano I. , Mai M. , et al. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998; 79: 187-194.

34.

Kabashima A. , Maehara Y. , Kakeji Y. , et al. Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000; 6: 3581-3584.

35.

Ogata R. , Torimura T. , Kin M. , et al. Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum Pathol 1999; 30: 443-450.

36.

Tam EM , Moore TR , Butler GS , et al. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J Biol Chem 2004; 279: 43336-43344.

37.

Munshi HG , Wu YI , Mukhopadhyay S. , et al. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 2004; 279: 39042-39050.

38.

Zhong J. , Gencay MM , Bubendorf L. , et al. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol 2006; 207: 540-552.

39.

Mitra A. , Chakrabarti J. , Banerji A. , et al. Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol 2006; 132: 505-513.

40.

Zhang D. , Bar-Eli M. , Meloche S. , et al. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J Biol Chem 2004; 279: 19683-19690.

41.

Nee L. , Tuite N. , Ryan MP , et al. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Exp Nephrol 2007; 107: e73-e86.

42.

Cowden Dahl KD , Symowicz J. , Ning Y. , et al. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 2008; 68: 4606-4613.

43.

Hollborn M. , Stathopoulos C. , Steffen A. , et al. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci 2007; 48: 4360-4367.

44.

Lee SO , Jeong YJ , Kim M. , et al. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun 2008; 366: 1019-1024.

45.

Zeisberg M. , Maeshima Y. , Mosterman B. , et al. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 2002; 160: 2001-2008.

46.

Cho HJ , Kang JH , Kwak JY , et al. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms . Carcinogenesis 2007; 28: 1104-1110.

47.

Zhang S. , Li Z. , Wu X. , et al. Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/ 2-ERK1/2 signaling pathway. Mol Cancer Ther 2006; 5: 3285-3293.

48.

Chung TW , Lee YC , Kim CH Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential . FASEB J 2004; 18: 1123-1125.

49.

Chakraborti S. , Mandal M. , Das S. , et al. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-285.

50.

Simon C. , Simon M. , Vucelic G. , et al. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res 2001; 271: 344-355.

51.

Woo JH , Lim JH , Kim YH , et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction . Oncogene 2004; 23: 1845-1853.

52.

Duffy MJ , Maguire TM , McDermott EW , et al. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer. J Surg Oncol 1999; 71: 130-135.

53.

Kwaan HC The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992; 11: 291-311.

54.

Chen PN , Hsieh YS , Chiou HL , et al. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact 2005; 156: 141-150.

55.

Kwon GT , Cho HJ , Chung WY , et al. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009; 20: 663-676.

56.

Lee SJ , Park SS , Lee US , et al. Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anticancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 2008; 8: 1821-1826.

57.

Sun LC , Luo J. , Mackey LV , et al. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 2007; 246: 157-166.